Canada Clinical Nutrition Market Synopsis:

Canada Clinical Nutrition Market Was Valued at USD 677.62 Million in 2023 and is projected to reach USD 1132.25 Million by 2032, growing at a CAGR of 5.87% from 2024 to 2032.

The Canada Clinical Nutrition Market refers to the sector focused on the production, distribution, and consumption of specialized nutritional products aimed at managing medical conditions, supporting recovery, or enhancing the health of patients with specific dietary needs. These products, including enteral nutrition (oral supplements and tube feeding formulas) and parenteral nutrition (intravenous nutrition), are designed to support individuals with chronic illnesses, malnutrition, digestive disorders, or those recovering from surgery..

The Canada Clinical Nutrition Market has been comparatively slow in growth, the growth factors are shifting gears with addition of chronic diseases, elderly populations, and growing knowledge of nutrition’s role in medical treatments. Enteral and parenteral products are getting more and more a part of clinical nutrition therapies of patients who suffer from such diseases as malnutrition, cancer, diabetes, and gastrointestinal diseases.

In the current world, there has been encouragement of a higher spending on healthcare needs and necessities due to the expanding population base and there is the need for nutrition to act as a modality in preventing diseases and assisting in recovery. That is because, as Canadians’ age, they require prescriptive clinical nutrition solutions that are linked to the aging process pathologies such as frailty and immunosenescence. Addtionally key factors that augment the market include the rebarch development of new formulation of nutrients, especially improvements in the formulation delivery mechanisms. The market is also experiencing increased number of developed product special to certain conditions like the parenteral nutrition for those patients with inability to take food orally and enteral nutrition for those with compromised digestion mechanisms. The market for clinical nutrition is progressively growing in the coming years due to developments in healthcare expectations from the healthcare providers and patients.

Canada Clinical Nutrition

Canada Clinical Nutrition Market Trend Analysis:

Driving the Growth of the Canada Clinical Nutrition Market

  • The key prevailing trend in the analyzed sphere of Canada’s Clinical Nutrition Market is the increased concern with the influence that the effectively regulated clinical nutrition can produce on chronic diseases. Diseases like diabetes, cancer, gastrointestinal disorders and malnutrition in both children and elderly population are now being treated using clinical nutrition. Studies have also pointed out that as people in Canada grow older there is increasing demand for nutrition products for the old age people. This has increased the demand of enteral nutrition formulas, parenteral nutrition solutions and other nutritious supplements designed for the Chronic Illness patients. Such products assist in the enhancement of health status of the patient, decrease on admission rates and general improvement of the quality of life of the patient.

  • the concept of personalization of nutrition is becoming a growing tendency in Canada. This approach inures on the basis of prescribing nutrient solutions to meet the person’s health requirements; minimising genetic predispositions, way of life, and diseases. Nutrition intervention of an individual is considered as a more effective solution, since the customer receives the necessary nutrients anytime to improve their health state. This change is accordance with the progress in knowledge of nutrients and the tendencies in engineering offering the increasing demand in individual nutrition. Since both caregivers and the consumers are inclined to acknowledge the worth of this strategy, the availability of personalized nutrition products and service is on the rise thereby gaining the market for clinical nutrition in Canada.

Growing Demand for Tailored Clinical Nutrition in Canada

  • The ageing population of Canadians is building up constantly, essential nutrients required for managing ailment such as frailty, osteoporosis, and malnutrition are in great demand. These diseases are usual with elderly people, which result to loss of ability to feed or assimilate nutrients in the body. This scenario develops a highly appealing market opportunity for clinical nutrition products such as enteral and parenteral nutrition formulas. These specialized products are intended to give essential nutrition right into the body when it is not always possible to eat a regular diet, therefore, they are very useful both in hospital and home environments. Due to the increasing prevalence of such a population, the demand for these products should persist and contribute to market development.

  • This is partly due to the aging population but also the increased consciousness of the part that nutrition plays in preventing as well as managing chronic diseases. By the help of nutritional care, it is now widely known that nutrition is an essential component of the treatment of diseases including diabetes, cardiovascular diseases, and cancer. These changes are helping to boost clinical nutrition product adoption in numerous healthcare stages. As people are getting more conscious about their health hospitals and homecare providers are likely to implement inclusive nutrition care plans which will in turn, create new business opportunities for these companies. The emphasis on nutrition in the healthy eating as a part of successful weight management will also help the Canadian clinical nutrition market to remain a consistently growing industry and a standard for all involved – patients, health care providers and clinical nutrition providers.

Canada Clinical Nutrition Market Segment Analysis:

Canada Clinical Nutrition Market Segmented on the basis of Type and Application

By Type, Enteral Nutrition segment is expected to dominate the market during the forecast period

  • It is a medical bridge by which required nutrients are delivered to the gastrointestinal tract of human beings who cannot take foods through their mouth but have a working GI tract. Primarily, this method is useful for patients who have certain diseases, for example, stroke, head injuries or neurological affections, or severe anorexia, and cannot eat normally. Enteral nutrition is realised by delivery of enteral products in liquid, powder and semi-solid forms for patients with the specified dietary needs. People require enough caloric intake, proteins, fats, vitamins, and minerals for body health, healing and proper functioning.

  • Enteral nutrition is being on the rise as a result of increase in incidence of chronic diseases, the growing aging population, and patients who have conditions that do not allow them to take food orally. As the elderly population continues to increase, more people are developing age-related health complications that include dysphagia a condition that enhances the use of enteral feeding. Furthermore, the emerging cases of diseases ranging from cancer, neurological disorders, gastrointestinal illnesses, and others, are usually accompanied by significant malnutrition problems, and this have also contributed to the growth of the market. The availability of the newer generation of enteral nutrition formulas that offer better bioavailability and patient personalized nutrition support is also making enteral feeding a standard medical therapy.

By Application, Malnutrition segment expected to held the largest share

  • Under nutrition and over nutrition together is a severe health problem that affects a large fraction of the global population, and it is manifested by an undesirable diet that predisposes a person to several diseases. It is most common in patients with chronic illnesses who are unable to take sufficient food through the mouth and/or throat. Clinical nutrition and nutritional support such as enteral and parenteral nutrition may be employed to combat malnutrition because inappropriately nourished patients receive their nutrients intravenously or through feeding tubes. This type of feeding is helpful to patents with such diseases as cancer, injuries, stroke, certain gastrointestinal disorders or any condition that prevents effective oral feeding. Since malnutrition is a major problem in health care involving patients across the globe, there is ever increasing need for nutritional services especially in hospitals and other care institutions.

  • Mr Lonely mentions that many people of interest are not just malnourished but cachectic, and this is more obvious in developing countries because of restricted food rationing, and among aging citizens because of their medical states including dementia, cancer, and frailty. Common in developed countries, malnutrition affects mainly the elderly, those with varying diseases of the old age or effects of cancer treatments that alter eating habits and nutrient assimilation patterns. Protein and energy administration by enteral and parenteral feeds is very vital in the overall management of the patients to increase the recovery rate and to prevent the worsening of the other complications in the body. With the increasing number of people of pension age and steadily growing prevalence of chronic diseases, it is crucial to apply the methods of active nutrition to fight malnutrition.

Active Key Players in the Canada Clinical Nutrition Market

  • Nestlé Health Science

  • Abbott Laboratories
  • Danone Nutricia
  • Baxter International Inc.
  • Cardinal Health
  • Fresenius Kabi
  • Hickory Farms
  • Other Active Players

Canada Clinical Nutrition Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 677.62 Million

Forecast Period 2024-32 CAGR:

 5.87%

Market Size in 2032:

USD 1132.25 Million

Segments Covered:

By Type

  • Enteral Nutrition
  • Parenteral Nutrition
  • Infant Nutrition

By Application

  • Malnutrition
  • Diabetes
  • Cancer
  • Gastrointestinal Disorders
  • Critical Care
  • Others

Key Market Drivers:

  • Increasing Awareness about the Nutrition Among Canadian Population

Key Market Restraints:

  • High Product Costs

Key Opportunities:

  • Innovations in Product Development

Companies Covered in the report:

  • Nestlé Health Science, Abbott Laboratories, Danone Nutricia, Baxter International Inc., Cardinal Health, and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Canada Clinical Nutrition Market by Type
 4.1 Canada Clinical Nutrition Market Snapshot and Growth Engine
 4.2 Canada Clinical Nutrition Market Overview
 4.3 Enteral Nutrition
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Enteral Nutrition: Geographic Segmentation Analysis
 4.4 Parenteral Nutrition and Infant Nutrition
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Parenteral Nutrition and Infant Nutrition: Geographic Segmentation Analysis

Chapter 5: Canada Clinical Nutrition Market by Application
 5.1 Canada Clinical Nutrition Market Snapshot and Growth Engine
 5.2 Canada Clinical Nutrition Market Overview
 5.3 Malnutrition
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Malnutrition: Geographic Segmentation Analysis
 5.4 Diabetes
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Diabetes: Geographic Segmentation Analysis
 5.5 Cancer
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Cancer: Geographic Segmentation Analysis
 5.6 Gastrointestinal Disorders
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Gastrointestinal Disorders: Geographic Segmentation Analysis
 5.7 Critical Care and Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Critical Care and Others: Geographic Segmentation Analysis

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Benchmarking
  6.1.2 Canada Clinical Nutrition Market Share by Manufacturer (2023)
  6.1.3 Industry BCG Matrix
  6.1.4 Heat Map Analysis
  6.1.5 Mergers and Acquisitions  
 6.2 NESTLÉ HEALTH SCIENCE
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Role of the Company in the Market
  6.2.5 Sustainability and Social Responsibility
  6.2.6 Operating Business Segments
  6.2.7 Product Portfolio
  6.2.8 Business Performance
  6.2.9 Key Strategic Moves and Recent Developments
  6.2.10 SWOT Analysis
 6.3 ABBOTT LABORATORIES
 6.4 DANONE NUTRICIA
 6.5 BAXTER INTERNATIONAL INC.
 6.6 CARDINAL HEALTH
 6.7 FRESENIUS KABI
 6.8 HICKORY FARMS
 6.9 OTHER ACTIVE PLAYERS

Chapter 7: Global Canada Clinical Nutrition Market By Region
 7.1 Overview
7.2. North America Canada Clinical Nutrition Market
  7.2.1 Key Market Trends, Growth Factors and Opportunities
  7.2.2 Top Key Companies
  7.2.3 Historic and Forecasted Market Size by Segments
  7.2.4 Historic and Forecasted Market Size By Type
  7.2.4.1 Enteral Nutrition
  7.2.4.2 Parenteral Nutrition and Infant Nutrition
  7.2.5 Historic and Forecasted Market Size By Application
  7.2.5.1 Malnutrition
  7.2.5.2 Diabetes
  7.2.5.3 Cancer
  7.2.5.4 Gastrointestinal Disorders
  7.2.5.5 Critical Care and Others
  7.2.6 Historic and Forecast Market Size by Country
  7.2.6.1 US
  7.2.6.2 Canada
  7.2.6.3 Mexico
7.3. Eastern Europe Canada Clinical Nutrition Market
  7.3.1 Key Market Trends, Growth Factors and Opportunities
  7.3.2 Top Key Companies
  7.3.3 Historic and Forecasted Market Size by Segments
  7.3.4 Historic and Forecasted Market Size By Type
  7.3.4.1 Enteral Nutrition
  7.3.4.2 Parenteral Nutrition and Infant Nutrition
  7.3.5 Historic and Forecasted Market Size By Application
  7.3.5.1 Malnutrition
  7.3.5.2 Diabetes
  7.3.5.3 Cancer
  7.3.5.4 Gastrointestinal Disorders
  7.3.5.5 Critical Care and Others
  7.3.6 Historic and Forecast Market Size by Country
  7.3.6.1 Russia
  7.3.6.2 Bulgaria
  7.3.6.3 The Czech Republic
  7.3.6.4 Hungary
  7.3.6.5 Poland
  7.3.6.6 Romania
  7.3.6.7 Rest of Eastern Europe
7.4. Western Europe Canada Clinical Nutrition Market
  7.4.1 Key Market Trends, Growth Factors and Opportunities
  7.4.2 Top Key Companies
  7.4.3 Historic and Forecasted Market Size by Segments
  7.4.4 Historic and Forecasted Market Size By Type
  7.4.4.1 Enteral Nutrition
  7.4.4.2 Parenteral Nutrition and Infant Nutrition
  7.4.5 Historic and Forecasted Market Size By Application
  7.4.5.1 Malnutrition
  7.4.5.2 Diabetes
  7.4.5.3 Cancer
  7.4.5.4 Gastrointestinal Disorders
  7.4.5.5 Critical Care and Others
  7.4.6 Historic and Forecast Market Size by Country
  7.4.6.1 Germany
  7.4.6.2 UK
  7.4.6.3 France
  7.4.6.4 The Netherlands
  7.4.6.5 Italy
  7.4.6.6 Spain
  7.4.6.7 Rest of Western Europe
7.5. Asia Pacific Canada Clinical Nutrition Market
  7.5.1 Key Market Trends, Growth Factors and Opportunities
  7.5.2 Top Key Companies
  7.5.3 Historic and Forecasted Market Size by Segments
  7.5.4 Historic and Forecasted Market Size By Type
  7.5.4.1 Enteral Nutrition
  7.5.4.2 Parenteral Nutrition and Infant Nutrition
  7.5.5 Historic and Forecasted Market Size By Application
  7.5.5.1 Malnutrition
  7.5.5.2 Diabetes
  7.5.5.3 Cancer
  7.5.5.4 Gastrointestinal Disorders
  7.5.5.5 Critical Care and Others
  7.5.6 Historic and Forecast Market Size by Country
  7.5.6.1 China
  7.5.6.2 India
  7.5.6.3 Japan
  7.5.6.4 South Korea
  7.5.6.5 Malaysia
  7.5.6.6 Thailand
  7.5.6.7 Vietnam
  7.5.6.8 The Philippines
  7.5.6.9 Australia
  7.5.6.10 New Zealand
  7.5.6.11 Rest of APAC
7.6. Middle East & Africa Canada Clinical Nutrition Market
  7.6.1 Key Market Trends, Growth Factors and Opportunities
  7.6.2 Top Key Companies
  7.6.3 Historic and Forecasted Market Size by Segments
  7.6.4 Historic and Forecasted Market Size By Type
  7.6.4.1 Enteral Nutrition
  7.6.4.2 Parenteral Nutrition and Infant Nutrition
  7.6.5 Historic and Forecasted Market Size By Application
  7.6.5.1 Malnutrition
  7.6.5.2 Diabetes
  7.6.5.3 Cancer
  7.6.5.4 Gastrointestinal Disorders
  7.6.5.5 Critical Care and Others
  7.6.6 Historic and Forecast Market Size by Country
  7.6.6.1 Turkiye
  7.6.6.2 Bahrain
  7.6.6.3 Kuwait
  7.6.6.4 Saudi Arabia
  7.6.6.5 Qatar
  7.6.6.6 UAE
  7.6.6.7 Israel
  7.6.6.8 South Africa
7.7. South America Canada Clinical Nutrition Market
  7.7.1 Key Market Trends, Growth Factors and Opportunities
  7.7.2 Top Key Companies
  7.7.3 Historic and Forecasted Market Size by Segments
  7.7.4 Historic and Forecasted Market Size By Type
  7.7.4.1 Enteral Nutrition
  7.7.4.2 Parenteral Nutrition and Infant Nutrition
  7.7.5 Historic and Forecasted Market Size By Application
  7.7.5.1 Malnutrition
  7.7.5.2 Diabetes
  7.7.5.3 Cancer
  7.7.5.4 Gastrointestinal Disorders
  7.7.5.5 Critical Care and Others
  7.7.6 Historic and Forecast Market Size by Country
  7.7.6.1 Brazil
  7.7.6.2 Argentina
  7.7.6.3 Rest of SA

Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies

Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
 

Canada Clinical Nutrition Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 677.62 Million

Forecast Period 2024-32 CAGR:

 5.87%

Market Size in 2032:

USD 1132.25 Million

Segments Covered:

By Type

  • Enteral Nutrition
  • Parenteral Nutrition
  • Infant Nutrition

By Application

  • Malnutrition
  • Diabetes
  • Cancer
  • Gastrointestinal Disorders
  • Critical Care
  • Others

Key Market Drivers:

  • Increasing Awareness about the Nutrition Among Canadian Population

Key Market Restraints:

  • High Product Costs

Key Opportunities:

  • Innovations in Product Development

Companies Covered in the report:

  • Nestlé Health Science, Abbott Laboratories, Danone Nutricia, Baxter International Inc., Cardinal Health, and Other Active Players.

Frequently Asked Questions :

What would be the forecast period in the Canada Clinical Nutrition Market research report?
The forecast period in the Canada Clinical Nutrition Market research report is 2024-2032.
Who are the key players in the Canada Clinical Nutrition Market?
Nestlé Health Science, Abbott Laboratories, Danone Nutricia, Baxter International Inc., Cardinal Health, Fresenius Kabi, Hickory Farms, and Other Active Players.
What are the segments of the Canada Clinical Nutrition Market?
The Canada Clinical Nutrition Market is segmented into By Type, By Application and region. By Type, the market is categorized into Enteral Nutrition, Parenteral Nutrition and Infant Nutrition. By Application, the market is categorized into Malnutrition, Diabetes, Cancer, Gastrointestinal Disorders, Critical Care and Others. By region, it is analyzed across North America (U.S., Canada, Mexico),Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe),Western Europe (Germany, UK, France, Netherlands, Italy, Spain, Rest of Western Europe),Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC),Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa),South America (Brazil, Argentina, Rest of SA).
What is the Canada Clinical Nutrition Market?
The Canada Clinical Nutrition Market refers to the sector focused on the production, distribution, and consumption of specialized nutritional products aimed at managing medical conditions, supporting recovery, or enhancing the health of patients with specific dietary needs. These products, including enteral nutrition (oral supplements and tube feeding formulas) and parenteral nutrition (intravenous nutrition), are designed to support individuals with chronic illnesses, malnutrition, digestive disorders, or those recovering from surgery.
How big is the Canada Clinical Nutrition Market?
Canada Clinical Nutrition Market Was Valued at USD 677.62 Million in 2023 and is projected to reach USD 1132.25 Million by 2032, growing at a CAGR of 5.87% from 2024 to 2032.